← Evidence map

ArticleOncotarget2017

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.

Dong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28460430